Santa Clara University

Russ Sampson

President and CEO, Sierra Surgical Technologies

Russ Sampson has been the President and CEO of Sierra Surgical Technologies since 2007. Sierra Surgical Technologies is a development stage company focuses on minimally invasive surgical systems. From 1998 to 2004, Russel Sampson was the Vice President of Research & Development for Novacept, Inc, a privately held med-tech firm in Palo Alto focused on women's health. The company's flagship product is an RF electrosurgical system used in the treatment of menorrhagia. In March, 2004 Novacept was acquired by Cytyc Corporation, a Massachusetts based company focused on cytology for women's health. From 1998 to 2004 he served as the Vice President of Research & Development for Cytyc Surgical Products, a division of Cytyc Corporation. From 1996 to 1998, he served in various engineering and management positions within Novacept's R&D group. Prior to joining Novacept, he was engaged in the development of electromechanical drug delivery systems for the Hospital Products Division of Abbott laboratories from 1991 to 1996, first as an R&D Engineer, then as a Member of Technical Staff. Abbott HPD developed hospital based systems with applications in the medical-surgical, ICU and coronary care units. From 1986 to 1991 Russel was an R&D Engineer in the Mechanical Engineering Laboratory of Space Systems/Loral, an astronautics company engaged in the development of geosynchronous communication and weather satellites. Within the Solar Array Subsystems group of the ME Laboratory, he was involved in the design and development of mechanisms used to deploy satellites' antennas and solar panels once the satellites achieved orbit. He received his BS in Applied Mechanics and Engineering Sciences from the University of California, San Diego and is a licensed Professional Engineer. He holds 23 issued US patents and several international patents, with 30 additional US and international patents pending.